Back to Search
Start Over
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
- Source :
- Trials, Vol 21, Iss 1, Pp 1-1 (2020)
- Publication Year :
- 2020
- Publisher :
- BMC, 2020.
-
Abstract
- An amendment to this paper has been published and can be accessed via the original article.
- Subjects :
- Medicine (General)
R5-920
Subjects
Details
- Language :
- English
- ISSN :
- 17456215
- Volume :
- 21
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Trials
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.30aec88a445e44dab92599746ef9197f
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s13063-020-04947-2